Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Experimental RNAi02:15

Experimental RNAi

6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gancao Ganjiang Decoction Inhibits Renal Cell Carcinoma Progression via PI3K-AKT and JAK-STAT Signaling Pathways.

Chinese journal of integrative medicine·2026
Same author

Dietary High Fiber and N-Carbamylglutamate Enhance Sow Reproductive Performance via Modulating Lactobacilli, Lipid Metabolites, and the PI3K-Akt Signaling Pathway.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Network-based analysis of crucial genes for salt tolerance in rice.

Plant physiology·2026
Same author

Circulating multiple metals and mortality after myocardial infarction: incremental value beyond GRACE.

American journal of preventive cardiology·2026
Same author

Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report.

Frontiers in medicine·2026
Same author

TURBT versus RC in T1N0M0 non-urothelial bladder cancer: a population-based study.

Frontiers in oncology·2026

Related Experiment Video

Updated: Jul 11, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.2K

Anticancer benzoxaboroles block pre-mRNA processing by directly inhibiting CPSF3.

Ye Tao1, Albert Budhipramono2, Ji Huang3

  • 1Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Cell Chemical Biology
|November 15, 2023
PubMed
Summary

Novel benzoxaboroles kill cancer cells by inhibiting CPSF3, an enzyme crucial for gene expression. This discovery opens new avenues for developing targeted cancer therapies by targeting this specific mechanism.

More Related Videos

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

960
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.1K

Related Experiment Videos

Last Updated: Jul 11, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.2K
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

960
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.1K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • A novel class of benzoxaboroles has demonstrated the ability to induce cancer cell death.
  • The precise mechanism underlying benzoxaborole-induced cancer cell death remained unidentified.

Purpose of the Study:

  • To elucidate the mechanism by which benzoxaboroles induce cancer cell death.
  • To identify the molecular target of benzoxaboroles and their role in cancer biology.

Main Methods:

  • Utilized a forward genetics platform to identify resistance mechanisms.
  • Employed in vitro biochemical assays to assess enzyme inhibition.
  • Conducted X-ray crystallography to determine the binding mode of benzoxaboroles to CPSF3.
  • Evaluated the anti-cancer effects of benzoxaboroles on various cancer cell lines.

Main Results:

  • Mutations in cleavage and polyadenylation specific factor 3 (CPSF3) were found to confer resistance to benzoxaboroles.
  • Benzoxaboroles were shown to inhibit the endonuclease activity of CPSF3 in vitro.
  • Inhibition of CPSF3 by benzoxaboroles curbed transcriptional termination in cells, leading to the downregulation of essential genes.
  • X-ray crystallography revealed a unique binding interaction between benzoxaboroles and the active site of CPSF3.
  • Benzoxaborole compounds effectively impeded the growth of diverse cancer cell lines.

Conclusions:

  • Benzoxaboroles function by inhibiting the endonuclease activity of CPSF3, a key enzyme in pre-mRNA processing and transcription termination.
  • The distinct binding mechanism of benzoxaboroles to CPSF3 offers a novel approach for drug development.
  • Benzoxaboroles show significant potential as a new class of CPSF3 inhibitors for cancer therapy.